Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zhiwen Yao
Is Time to Progression Associated With Post-Progression Survival in Previously Treated Metastatic Non-Small Cell Lung Cancer With BRAF V600E Mutation? A Secondary Analysis of Phase II Clinical Trial Data
BMJ Open
Medicine
Deflazacort Versus Prednisone Treatment for Duchenne Muscular Dystrophy: A Meta‐analysis of Disease Progression Rates in Recent Multicenter Clinical Trials
Muscle and Nerve
Molecular Neuroscience
Neurology
Physiology
Cellular
Related publications
Phase II Study of S-1 and Docetaxel for Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Genetic Polymorphisms Associated With a Prolonged Progression-Free Survival in Patients With Metastatic Renal Cell Cancer Treated With Sunitinib
Clinical Cancer Research
Cancer Research
Oncology
A Multi-Center, Phase II Trial of Nab-Paclitaxel and Gemcitabine in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
Cancer Management and Research
Oncology
Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
Cancer Research and Treatment
Cancer Research
Oncology
Identification of Serum Proteome Components Associated With Progression of Non-Small Cell Lung Cancer.
Acta Biochimica Polonica
Biochemistry
Genetics
Molecular Biology
Thymidine Phosphorylase Expression Is Associated With Time to Progression in Patients With Metastatic Colorectal Cancer
BMC Clinical Pathology
Forensic Medicine
Pathology
Histology
Role of Survival Post-Progression in Phase III Trials of Systemic Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Systemic Review
PLoS ONE
Multidisciplinary
P3.01-05 Mature Progression-Free Survival in Stage IV Non-Small Cell Lung Cancer Patients Treated With Pemetrexed Maintenance Therapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
TP53 Mutation Is Associated With a Poor Clinical Outcome for Non-Small Cell Lung Cancer: Evidence From a Meta-Analysis
Molecular and Clinical Oncology
Cancer Research
Oncology
